newsfilter
← Latest News
GlobeNewswire·

Clene Reports Third Quarter 2025 Financial Results and Recent Operating Highlights

As the U.S. Food and Drug Administration (FDA) proposed, Clene is concluding analyses of its ALS biomarker data with completion planned shortly The FDA advised Clene to request a Type C meeting to review these further